bendamustine hydrochloride has been researched along with Leukemia, Hairy Cell in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imoto, N; Koyama, D; Kurahashi, S; Sugiura, I | 1 |
| Li, HC; Sadeghi, N | 1 |
| Doll, D; Letendre, P | 1 |
| Arons, E; Burotto, M; Kreitman, RJ; Stetler-Stevenson, M; Wilson, W; Zhou, H | 1 |
| Arons, E; Kreitman, RJ; Miller, KB; Stetler-Stevenson, M | 1 |
5 other study(ies) available for bendamustine hydrochloride and Leukemia, Hairy Cell
| Article | Year |
|---|---|
Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Rituximab | 2021 |
MRD-negative complete remission in relapsed refractory hairy cell leukemia with bendamustine and obinutuzumab.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Bendamustine Hydrochloride; Female; Humans; Leukemia, Hairy Cell; Remission Induction | 2018 |
Novel therapeutics in the treatment of hairy cell leukemia variant.
Topics: Adenine; Aged; Aged, 80 and over; Antineoplastic Agents; Bendamustine Hydrochloride; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Piperidines; Pyrazoles; Pyrimidines; Rituximab | 2018 |
Bendamustine and rituximab in relapsed and refractory hairy cell leukemia.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Blood Platelets; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Administration Schedule; Female; Humans; Immunologic Factors; Leukemia, Hairy Cell; Lymphocyte Count; Male; Middle Aged; Nitrogen Mustard Compounds; Pilot Projects; Platelet Count; Remission Induction; Rituximab; Treatment Outcome | 2013 |
Response of hairy cell leukemia to bendamustine.
Topics: Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Humans; Interleukin-2 Receptor alpha Subunit; Leukemia, Hairy Cell; Male; Middle Aged; Nitrogen Mustard Compounds; Sialic Acid Binding Ig-like Lectin 2; Treatment Outcome; Tumor Burden | 2011 |